DexCom, Google Partner to Develop Smaller, Cheaper Glucose Meters
This article was originally published in The Gray Sheet
Executive Summary
The companies hope their partnership will result in the development of cheap, bandage-sized continuous glucose monitors that will become standard of care for diabetes healthcare. DexCom also says that aggregating data from patients will allow it to make a big splash in the type 2 diabetes market.
You may also be interested in...
Medtronic Builds Toward Integrated Care With A String Of Diabetes Deals
Medtronic inking four diabetes deals in about a month's time is no coincidence. The company wants to transform itself from a device maker that sells mostly to type 1 diabetics, into an integrated-care company that serves the broader diabetes community, and it does not have all the capabilities it needs to accomplish that feat in house, explains Hooman Hakami, who heads Medtronic's diabetes unit.
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.